Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVP + HIVIGLOB or Extended NVP for Prevention of Maternal-Infant HIV Transmission
NCT00639938Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2004
- Primary completion
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 3 trial of nevirapine, anti-HIV immune serum globulin in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2004; status: completed.
02
Drugs
nevirapineanti-HIV immune serum globulin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00639938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00639938.